Literature DB >> 21427640

The impact of DSM-IV symptom and clinical significance criteria on the prevalence estimates of subthreshold and threshold anxiety in the older adult population.

Sébastien Grenier1, Michel Préville, Richard Boyer, Kieron O'Connor, Sarah-Gabrielle Béland, Olivier Potvin, Carol Hudon, Joëlle Brassard.   

Abstract

OBJECTIVES: Subthreshold anxiety refers to a condition where individuals do not meet the full symptom criteria (i.e., the number of symptoms required for a formal diagnosis is not reached) and/or do not report significant impairment or distress in functioning (i.e., the clinical significance criterion is not met). The purpose of this study was to examine how the symptom and the clinical significance criteria may affect the prevalence estimates of anxiety problems in the older adult population and whether applying these criteria results in an identifiable older group showing more severe anxiety. SETTING AND PARTICIPANTS: Data came from a large representative sample of community-dwelling older adults age 65 years and older (N = 2,784).
RESULTS: Results showed that the 12-month prevalence rate of any anxiety problem varied from 5.6% when DSM-IV criteria for anxiety disorders were used to 26.2% when all subthreshold manifestations of anxiety were considered. Findings also indicated that when compared with respondents without anxiety, older adults presenting different manifestations of subthreshold or threshold anxiety appear to be more similar than different in their health and health behavior characteristics.
CONCLUSIONS: Subthreshold anxiety has a high prevalence and may cause significant impairment. Both symptom and clinical significance criteria do not perfectly discriminate between older adults with or without a severe anxiety problem presenting comorbid disorders and needing psychiatric help.

Entities:  

Mesh:

Year:  2011        PMID: 21427640      PMCID: PMC3682986          DOI: 10.1097/JGP.0b013e3181ff416c

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  36 in total

Review 1.  DSM-IV diagnostic criterion for clinical significance: does it help solve the false positives problem?

Authors:  R L Spitzer; J C Wakefield
Journal:  Am J Psychiatry       Date:  1999-12       Impact factor: 18.112

2.  Empirical impact of DSM-IV diagnostic criterion for clinical significance.

Authors:  Tim Slade; Gavin Andrews
Journal:  J Nerv Ment Dis       Date:  2002-05       Impact factor: 2.254

3.  Mild disorders should not be eliminated from the DSM-V.

Authors:  Ronald C Kessler; Kathleen R Merikangas; Patricia Berglund; William W Eaton; Doreen S Koretz; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2003-11

Review 4.  Comorbidity of depression and anxiety disorders in later life.

Authors:  E J Lenze; B H Mulsant; M K Shear; G S Alexopoulos; E Frank; C F Reynolds
Journal:  Depress Anxiety       Date:  2001       Impact factor: 6.505

5.  Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates.

Authors:  William E Narrow; Donald S Rae; Lee N Robins; Darrel A Regier
Journal:  Arch Gen Psychiatry       Date:  2002-02

6.  Clinical significance and comorbidity of subthreshold depression and anxiety in the community.

Authors:  M Preisig; K R Merikangas; J Angst
Journal:  Acta Psychiatr Scand       Date:  2001-08       Impact factor: 6.392

7.  Subthreshold depressive and anxiety disorders in the elderly.

Authors:  R Heun; A Papassotiropoulos; U Ptok
Journal:  Eur Psychiatry       Date:  2000-05       Impact factor: 5.361

8.  DSM-IV criteria for generalized anxiety disorder in older adults: distinguishing the worried from the well.

Authors:  Julie Loebach Wetherell; Hillary Le Roux; Margaret Gatz
Journal:  Psychol Aging       Date:  2003-09

9.  Does the severity of mood and anxiety symptoms predict health care utilization?

Authors:  D E Nease; R J Volk; A R Cass
Journal:  J Fam Pract       Date:  1999-10       Impact factor: 0.493

10.  Psychiatric symptoms, impaired function, and medical care costs in an HMO setting.

Authors:  Enid M Hunkeler; William D Spector; Bruce Fireman; Dorothy P Rice; Constance Weisner
Journal:  Gen Hosp Psychiatry       Date:  2003 May-Jun       Impact factor: 3.238

View more
  26 in total

1.  Adjustment disorders: prevalence in a representative nationwide survey in Germany.

Authors:  Andreas Maercker; Simon Forstmeier; Laura Pielmaier; Lena Spangenberg; Elmar Brähler; Heide Glaesmer
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-03-11       Impact factor: 4.328

2.  Anxiety disorders: new developments in old age.

Authors:  Eric J Lenze; Julie Loebach Wetherell
Journal:  Am J Geriatr Psychiatry       Date:  2011-04       Impact factor: 4.105

Review 3.  Improving recognition of late life anxiety disorders in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition: observations and recommendations of the Advisory Committee to the Lifespan Disorders Work Group.

Authors:  Jan Mohlman; Christina Bryant; Eric J Lenze; Melinda A Stanley; Amber Gum; Alastair Flint; Aartjan T F Beekman; Julie Loebach Wetherell; Steven R Thorp; Michelle G Craske
Journal:  Int J Geriatr Psychiatry       Date:  2011-07-20       Impact factor: 3.485

4.  Trajectories of depressive and anxiety symptoms in older adults: a 6-year prospective cohort study.

Authors:  Sophie E Holmes; Irina Esterlis; Carolyn M Mazure; Yen Ying Lim; David Ames; Stephanie Rainey-Smith; Chris Fowler; Kathryn Ellis; Ralph N Martins; Olivier Salvado; Vincent Doré; Victor L Villemagne; Christopher C Rowe; Simon M Laws; Colin L Masters; Robert H Pietrzak; Paul Maruff
Journal:  Int J Geriatr Psychiatry       Date:  2017-07-24       Impact factor: 3.485

5.  Effect of external variables on the performance of the geriatric comorbidity score derived from prescription claims in the community-dwelling elderly.

Authors:  Sarah-Gabrielle Béland; Cara Tannenbaum; Thierry Ducruet; Michel Préville; Djamal Berbiche; Yola Moride
Journal:  Drugs Aging       Date:  2012-11       Impact factor: 3.923

6.  Anxiety trajectories in the second half of life: Genetic and environmental contributions over age.

Authors:  Lewina O Lee; Margaret Gatz; Nancy L Pedersen; Carol A Prescott
Journal:  Psychol Aging       Date:  2016-01-11

7.  Clinical Significance of Individual GAD Symptoms in Later Life.

Authors:  Beyon Miloyan; Nancy A Pachana
Journal:  J Geriatr Psychiatry Neurol       Date:  2015-09-16       Impact factor: 2.680

8.  Cortical Thickness and Anxiety Symptoms Among Cognitively Normal Elderly Persons: The Mayo Clinic Study of Aging.

Authors:  Anna Pink; Scott A Przybelski; Janina Krell-Roesch; Gorazd B Stokin; Rosebud O Roberts; Michelle M Mielke; Kathleen A Spangehl; David S Knopman; Clifford R Jack; Ronald C Petersen; Yonas E Geda
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2016-08-31       Impact factor: 2.198

Review 9.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

10.  Anxiety symptoms in older home health care recipients: prevalence and associates.

Authors:  Nimali Jayasinghe; Leila P Rocha; Thomas Sheeran; Katarzyna Wyka; Martha L Bruce
Journal:  Home Health Care Serv Q       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.